Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder
Frye RE, Rossignol DA, Scahill L, McDougle CJ, Huberman H, Quadros EV. Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder. Semin Pediatr Neurol 2020; 100835
Emerging biomarkers in autism spectrum disorder: a systematic review
Frye RE, Vassall S, Kaur G, Lewis C, Karim M, Rossignol DA. Emerging biomarkers in autism spectrum disorder: a systematic review. Ann Transl Med 2019;7(23):792
The use of NAC as a chelator for metal toxicity: a systematic review [Book chapter].
In The Therapeutic Use of N-Acetyl Cysteine in Medicine, 2018. Rossignol DA. Edited by Richard Frye and Michael Berk, Springer Publishing.
Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder
Mol Diagn Ther 2018; doi: 10.1007/s40291-018-0352-x. Rose S, Niyazov DM, Rossignol DA, Goldenthal M, Kahler SG, Frye RE.
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
Mol Psychiatry 2012;17(4):389-401
Frye and Rossignol reply: Response to meta-analyzing the effectiveness of melatonin for sleep-distrubed individuals with autism spectrum conditions: Should Rett syndrome be included?
Dev Med Child Neurol 2011;53(11):1064
Our family’s experience with biomedical treatments and hyperbaric oxygen therapy for autism
Autism Sci Dig, 2008
Hyperbaric oxygen therapy in autistic children improves symptomatology, decreases markers of inflammation, and has neutral effects on oxidative stress [Abstract 25]
Accelerated transplant coronary artery disease and massive silent acute myocardial infarction in a heart transplant patient–a case report and brief review of literature